To date, published case reports of DCTN1–ALK fusion solid tumors included non-small cell lung cancer (NSCLC) (9–11), inflammatory myofibroblastic tumors (IMTs) (12, 13), Spitz tumors (14), and some rare types of neoplasms. This evidence concerns the gene ALK and inflammatory myofibroblastic tumor.